Dr. Sulaiman Al Habib Medical Services Group reported a net profit of SAR 2.31 billion for 2024, an increase of 13% from SAR 2.04 billion in the year-earlier period.
Item | 2023 | 2024 | Change |
---|---|---|---|
Revenues | 9,508.44 | 11,200.43 | 17.8 % |
Gross Income | 3,270.05 | 3,744.26 | 14.5 % |
Operating Income | 2,095.65 | 2,356.26 | 12.4 % |
Net Income | 2,046.01 | 2,315.29 | 13.2 % |
Average Shares | 350.00 | 350.00 | - |
Earnings Per Share before unusual items (Riyals) | 5.68 | 6.49 | 14.2 % |
EPS (Riyals) | 5.85 | 6.62 | 13.2 % |
Revenue grew by 17.79% to SAR 11.2 billion, up from SAR 9.50 billion in the previous year, mainly driven by the growth in both hospital and pharmacy segments. In addition, the increase in patient numbers within the hospital segment had a direct positive impact on the pharmacy segment.
The group opened Al-Fayhaa Hospital (Al-Fayhaa - Jeddah) and Shamal Al Riyadh Hospital (Al-Sahafa - Riyadh), where both projects are currently in the revenue ramp-up phase during their first operational year.
Earnings before interest, taxes, depreciation and amortization (EBITDA) for 2024 increased by 18% YoY to SAR 2.97 million, as EBITDA margin reached 26.57% from 26.61% a year ago.
Item | Q4 2023 | Q4 2024 | Change |
---|---|---|---|
Revenues | 2,486.49 | 3,128.85 | 25.8 % |
Gross Income | 868.16 | 996.81 | 14.8 % |
Operating Income | 534.18 | 624.13 | 16.8 % |
Net Income | 525.01 | 613.77 | 16.9 % |
Average Shares | 350.00 | 350.00 | - |
Earnings Per Share before unusual items (Riyals) | 1.34 | 1.63 | 21.7 % |
EPS (Riyals) | 1.50 | 1.75 | 16.9 % |
Item | Q3 2024 | Q4 2024 | Change |
---|---|---|---|
Revenues | 2,976.56 | 3,128.85 | 5.1 % |
Gross Income | 992.10 | 996.81 | 0.5 % |
Operating Income | 624.38 | 624.13 | 0.0 % |
Net Income | 595.54 | 613.77 | 3.1 % |
Average Shares | 350.00 | 350.00 | - |
Earnings Per Share before unusual items (Riyals) | 1.70 | 1.63 | (4.5 %) |
EPS (Riyals) | 1.70 | 1.75 | 3.1 % |
Q4 2024 net profit rose 17% to SAR 613.77 million from SAR 525.01 million a year ago.
On a sequential basis, net earnings grew 3.1% from SAR 595.54 million in Q3 2024.
Total shareholders’ equity, after minority interest, stood at SAR 7.17 billion by Dec. 31, 2024, compared to SAR 6.48 billion a year earlier.
Attached Documents
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}